Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Inventory (2016 - 2026)

Angiodynamics' Inventory history spans 16 years, with the latest figure at $58.6 million for Q1 2026.

  • For Q1 2026, Inventory fell 7.17% year-over-year to $58.6 million; the TTM value through Feb 2026 reached $58.6 million, down 7.17%, while the annual FY2025 figure was $62.0 million, 2.29% up from the prior year.
  • Inventory reached $58.6 million in Q1 2026 per ANGO's latest filing, down from $65.6 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $65.9 million in Q4 2024 to a low of $48.0 million in Q1 2022.
  • Average Inventory over 5 years is $60.2 million, with a median of $62.0 million recorded in 2025.
  • Peak YoY movement for Inventory: skyrocketed 32.25% in 2023, then decreased 8.6% in 2024.
  • A 5-year view of Inventory shows it stood at $63.2 million in 2022, then rose by 1.7% to $64.3 million in 2023, then increased by 2.59% to $65.9 million in 2024, then dropped by 0.53% to $65.6 million in 2025, then decreased by 10.66% to $58.6 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Inventory are $58.6 million (Q1 2026), $65.6 million (Q4 2025), and $62.3 million (Q3 2025).